IRWD
IRONWOOD PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.56
+1.71%Forward multiples
Based on analyst estimates
- P/E forward
- 2.77x
- P/E 2026E
- 2.90x
- P/E 2027E
- 2.69x
- P/E 2028E
- 2.48x
- P/S forward
- 1.23x
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.47x
- PEG TTM
- 0.07x
- Price / book
- -3.63x
- Price / sales
- 1.51x
- Price / cash flow
- 3.17x
Enterprise value
- Enterprise value
- $906.0M
- EV / sales
- 2.33x
- EV / EBITDA
- 3.75x
- EV / EBIT
- 3.84x
- Market cap
- $588.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026